Analysts have recently evaluated Alkermes and provided 12-month price targets. The average target is $42.17, accompanied by a ...

UBS upgraded Alkermes (NASDAQ:ALKS) to Buy from Neutral on Tuesday, citing prospects for Irish biotech’s orexin 2 receptor ...

Novo Nordisk said on Thursday it plans to start late-stage trials of amycretin injection and oral drugs during the first ...

Alkermes is facing a significant delay for its ALKS 5461 candidate for major depressive disorder after the FDA turned down its marketing application. The negative outcome for the review isn’t ...

The pharmaceutical construction industry has seen explosive growth, a trend with substantial implications for healthcare industry, and global health outcomes. The COVID-19 pandemic underscored the ...

Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023, after Eli Lilly and Co on Wednesday said it will cut list prices by 70% for its most commonly prescribed insulin ...

Story June 11 - Vertex Pharmaceuticals: Vertex is trimming its Rhode Island footprint, leaving 125 staffers out of a job. The company's cell & gene R&D campus in Providence will be consolidated as ...

Visit a quote page and your recently viewed tickers will be displayed here.

Explore PTC Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PTCT.